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Introduction
The severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) pandemic has overwhelmed the health 
care system. In the United States, there has been an 
exponential increase in the number of cases, with most 
deaths in people aged 65 years or older (Le Couteur 
et al., 2020; Zhou et al., 2020). Different studies showed 
predictors of worse outcomes and prognosis. The 
Clinical Frailty scale (CFS) has shown better correlation 
between a patient’s baseline functional status/frailty and 
the duration of hospital stay as well as overall mortality 
(Hewitt et al., 2020). We present a case where the CFS 
was used to guide our clinical decision making.
Case
An 81-year-old lady with past medical history of hyper-
tension, type 2 diabetes mellitus and obesity presented 
to the emergency department due to shortness of breath 
for 3 days associated with generalized body weakness, 
dry cough, fever, chills, nausea, and diarrhea. She denied 
any recent travel or contact with COVID-19 (Coronavirus 
disease 2019) patients.
Her vital signs on admission: Heart rate: 79 beats per 
minute, Respiratory rate: 25 breaths per minute with 
oxygen saturation of 80% on room air, Temperature: 
100.4 Fahrenheit, Blood pressure: 127/58 mmHg. On 
physical exam she was tachypneic, in moderate respira-
tory distress, and had decrease breath sounds bilaterally.
The laboratory tests showed lymphopenia, hypokale-
mia, elevated International normalized ratio(INR),sedi- 
mentation rate, C reactive protein, ferritin, D-dimer, lac-
tate dehydrogenase(LDH) and a positive SARS-COV-2 
PCR, further laboratory values are presented in Table 1. 
The chest x-ray showed multifocal diffuse ground glass 
opacities.
The patient was transitioned to high flow nasal cannula 
(HFNC) at 60 liters/min with improvement of oxygen satu-
ration to 98%. She was started on dexamethasone 6 mg 
intravenous daily, enoxaparin 80 mg subcutaneous twice a 
day and potassium replacement with potassium chloride 
10 mEq intravenous. A unit of convalescent plasma was 
ordered but was unable to get it due to lack of it in the blood 
bank. Based on her poor clinical status, the palliative care 
team was consulted. Unfortunate, she did not count with an 
advance directive or medical power of attorney. We talked 
with the family to assess her CFS before admission. As per 
patient’s daughter, the patient used a walker to ambulate 
around the house and had recurrent falls in the last year. 
She required help to bathe, complete housework, and for 
970336 GGMXXX10.1177/2333721420970336Gerontology and Geriatric MedicineHuayanay and Luu
research-article20202020
1The University of Texas Rio Grande Valley, Edinburg, TX, USA
2University of Texas Rio Grande Valley, Edinburg, TX, USA
3Doctors Hospital at Renaissance, Edinburg, TX, USA
Corresponding Author:
Irma Huayanay, Doctors Hospital at Renaissance, The University  
of Texas Rio Grande Valley, 5501 S McColl Rd, Edinburg, TX 78539, 
USA. 
Email: irma.huayanayespinoza@utrgv.edu
Tough Decisions During the  
COVID 19 Pandemic: A Frail  
Latino Patient
Irma Huayanay, MD1,2,3  and Stephanie Luu, DO1,2,3
Abstract
The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had overwhelmed the 
healthcare system worldwide with multiple ethical dilemmas. Several tools have been used to assess risk factors in 
these patients. One of them, the Clinical Frailty scale, has shown good correlation between the patient functional 
status and hospital stay with overall mortality. We present a case were the Clinical Frailty Scale was used to assess 
patient management and goals of care.
Keywords
COVID-19, frail, clinical frailty scale, code status
Manuscript received: September 16, 2020; accepted: October 11, 2020.
2 Gerontology & Geriatric Medicine
meal preparation. Based on this report, we scored the 
patient’s CFS of 6, indicating moderate frailty. The pallia-
tive care team discussed code status with the family 
explaining prognosis in patients with poor functional sta-
tus. The family decided the patient should remain full code.
The following days remdesivir and colchicine were 
added to her regimen. The patient required several 
days of HFNC and was not able to be weaned off oxy-
gen. She was discharge home with oxygen and full 
code status.
Table 1. Laboratory analysis.
Blood analysis Result Reference range
Complete blood count White blood cell 14.4 (4.8–10.9)th/uL
Percent neutrophils 87.4 (49.0–77.6)%
Percent lymphocytes 5 (11.8–40.8)%
Percent monocytes 4.9 (3.70–11.80)%
Percent eosinophils 0 (0–4.8)%
Percent basophils 0.3 (0–1.3)%
Percent immature granulocytes 2.4 (0–1)%
Hemoglobin 13 (10.8–14.7)gm/dL
Hematocrit 40.1 (32.2–42.9)%
Mean corpuscular volume 87.7 (84–96)fL
Mean corpuscular hemoglobin 28.4 (28.3–32.3)pg
Mean corposcular hemoglobin 
concentration
32.4 (29.58–33.75)gm/dL
Platelet count 255 (146–388)th/uL
Red blood cell distribution width CV 13.7 (12.20–15.80)%
Red blood cell distribution width SD 43.9 (38.93–51.44)fL
Complete metabolic panel Sodium 140 (132–143)mmol/L
Potassium 3.4 (3.5–5.1)mmol/L
Chloride 105 (98–107)mmol/L





Anion gap 16 (2–12)mEq/L
AST 36 (13–39)IU/L
ALT 24 (7–52)IU/L
Alkaline phosphatase 69 (34–104)IU/L
Albumin 3.4 (3.7–4.9)gm/dL
Total bilirrubin 0.5 (0.2–1.2)mg/dL
Coagulation studies PT 13.7 (10.6–13)second
INR 1.16 (0.90–1.10)
PTT 23.8 (24–36.7)second
Inflammatory markers Sedimentation rate 109 2–30 mm/hr
C Reactive protein 25.7 <1 mg/dL
Lactic acid 1.87 (0.5–1.99)mmol/L
D-dimer 50,887 <500 ng/mL
Ferritin 531.3 (6–264)ng/mL
LDH 376 (140–271)IU/L
Molecular microbiology SARS-COV-2 PCR Detected Not detected





P/F ratio 109 ___
Note. AST = Aspartate aminotransferase; ALT = Alanine aminotransferase; PT = Prothrombin Time; INR = International normalized ratio; 
PTT = Partial thromboplastin time; LDH = Lactate dehydrogenase; PO2 = Partial pressure of oxygen; PCO2 = Partial pressure of carbon 
dioxide; HCO3 = Bicarbonate; FiO2 = Fraction of inspired oxygen.
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Discussion
On December 2019, an outbreak started in Wuhan, 
China with a novel coronavirus known as SARS-CoV-2, 
which has spread worldwide, causing the COVID-19 
pandemic (Zhou et al., 2020).
Several tools and risk factors have been used to 
determined poor prognosis/outcomes in these patients, 
like elderly age, high SOFA (sequential organ failure 
assessment) score, and D-dimer greater than 1 μg/mL 
(Zhou et al., 2020). Comorbidities such as cancer, 
chronic kidney disease, COPD (chronic obstructive 
pulmonary disease), obesity, heart failure, coronary 
artery disease, Type 2 diabetes mellitus and others are 
still being identify by the CDC (Centers for Disease 
Control and Prevention, 2019).
The worldwide pandemic came with difficult deci-
sions where ethical dilemmas had to be faced. For 
example, in Italy, the decision for who was prioritized 
for ventilation was based on the patient’s age, with the 
cutoff being at age 65 (Le Couteur et al., 2020). 
Fortunately, with the passage of time, other tools have 
been utilized to assess who might benefit from critical 
care management.
Recently, a previously known scale used in the 
elderly population has gained strong support for deci-
sion making. The CFS assess the frailty/functional sta-
tus of an elderly individual to predict death or need for 
institutional care (Rockwood et al., 2005). In the hos-
pital setting, it correlates with a prolonged hospital 
stay and risk for a complicated course of disease (Juma 
et al., 2016).
The NICE (National Institute for Health and Care 
Excellence) guidelines proposed that patients with 
CFS score of 5 or less are considered less frail and can 
likely benefit from critical care management. Those 
with CFS score of 5 or more may require critical care 
advice to guide the decision about treatment as there is 
uncertainty in the benefits of critical care management 
(Moug et al., 2020; NICE, 2020). The CFS is an 
invaluable tool to recognize patients who have an 
increased mortality risk, longer hospital stays, risk of 
readmission, severity of disease and identify the 
patients who might benefit from a discussion about 
code status(Arie, 2020; Juma et al., 2016; Leclerc 
et al., 2020; Moug et al., 2020; Swiss Society of 
Intensive Care Medicine, 2020).
Our patient showed CFS score of 6, categorized as 
moderately frail. Based on this score, we had a discus-
sion with the patient and her family about goals of care 
and explained pros and cons about further critical care 
management. The patient remained hospitalized for 
13 days, which correlates with longer hospital stay in 
patients with CFS:5-9, with also increase mortality 
compared to those who were not frail (Hewitt et al., 
2020). Furthermore, patients with higher CFS score 
have higher readmission rate compared with its peers 
not frail (Juma et al., 2016).
Another main discussion in this pandemic is the code 
status. Initially, the patient was unstable and unable to 
communicate her wishes. In addition, she did not have 
an advance directive, medical power of attorney and the 
family never discussed code status before. In this patient, 
like other patients in the Latino population, several fac-
tors affect the discussion of code status, they include 
religious beliefs, cultural ideas, ethnicity, and language 
barriers (Shen et al., 2016). In the city of McAllen, 
85.3% of the population is Latino (U.S. Census Bureau, 
2019), which contributes to disparities seen in end of life 
care planning (Shen et al., 2016). This pandemic showed 
us that one of the main priorities is to discuss goals of 
care, mostly with a life-threatening illness in frail adults 
(Curtis et al., 2020).
Conclusion
Multiple ethical dilemmas came up with this pan-
demic, where more tools are required to make crucial 
decisions for patients’ life. The CFS is a tool to guide 
the clinician about the benefit or not of more aggres-
sive measures in COVID-19 patients. Further studies 
and education need to be done in the Latino commu-
nity to improve a better understanding of goals of care 
and discussion about code status in frail adults in 
which due to multiple factors this topic is often glossed 
over.
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